Sotac Pharmaceuticals Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 1,423,200 (47%) | — | ₹1,580 Cr |
| NII (HNI) | — | 428,400 (14%) | — | ₹476 Cr |
| Retail | — | 998,400 (33%) | — | ₹1,108 Cr |
| Market Maker | — | 150,000 (5%) | — | ₹17 Cr |
| Σ Total | — | 3,000,000 (100%) | — | ₹33,300 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹133,200 |
| Retail (Max) | 13 | 15,600 | ₹1,731,600 |
| S-HNI (Min) | 14 | 16,800 | ₹1,864,800 |
| B-HNI (Min) | 67 | 80,400 | ₹8,924,400 |
Financial Statements Amount in ₹ Lakhs
| Metric | 30-Sep-22 | 31-Mar-22 | 31-Mar-21 |
|---|---|---|---|
| Revenue | 3,995 | 7,337 | 4,895 |
| Profit After Tax | 47 | 288 | -237 |
| Net Worth | 797 | 662 | 249 |
| Total Assets | 6,462 | 3,525 | 3,470 |
| Reserves & Surplus | 567 | 432 | 19 |
| Total Borrowing | 2,186 | 1,135 | 1,036 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- To Meet Working Capital Requirements – 10.80
- Investment in Subsidiary – 7.00
- Upgradation / Construction of Existing /New Building in the Existing Premises – 5.90
- General Corporate Purpose – 7.40
Company Overview
Incorporated in 2015, Sotac Pharmaceuticals Limited is a part of the SOTAC group, based in Gujarat. The company is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. The company's business is majorly on principle to principle basis with different marketers.
SOTAC is serving over 162 corporate clients on a loan license and/or contract manufacturing basis. With their vast experience in the pharmaceutical segment, the company is growing and enlarging its scale of operations every year.
Sotac Pharmaceuticals established its manufacturing facility in the year 2017. In the year, the company's manufacturing facility was installed with the capacity to manufacture 90 Crore tables/year, and 14 Crore Capsules/year.
With a combined experience of over 59 years in the pharmaceutical manufacturing Industry of the Promoters, the company is blooming and expanding in various horizons.